Kiess, Wieland, Prof. Dr. med.
Department of Pediatrics, Medical Faculty, UL
Professor for Pediatrics, Director of the Department of Pediatrics, University of Leipzig Medical Center (since 1998)
Role within partner site
LIFE Child, pediatrician with central expertise in developmental aspects of child health
Relevant work experience
2014- Foreign Adjunct Professor in Pediatrics at the Karolinska Institute Stockholm, Sweden
2009 Visiting Professor, Royal Children´s Hospital, Melbourne, Australien
2002-05 Dean of the Medical Faculty of Leipzig University
2009-12 Medical and Scientific Head of the Department of Women and Pediatric Medicine
1994-97 Senior lecturer, Giessen, Germany
1994 Certification as Diabetologist (DDG)
1993 Habilitation in Pediatrics (LMU Munich)
1992-93 Senior physician and lecturer, Munich, Germany
1992 Board certification in Pediatrics at the University’s Children Hospital Munich and at the National Cancer Institute, Metabolism Branch Endocrine Section, Bethesda, Maryland, USA
1985-88 Fellow and visiting scientist, National Cancer Institute, Metabolism Branch Endocrine Section, Bethesda, Maryland, USA
1984 Medical Thesis (LMU Munich)
1977-83 Medical School, Tübingen University and LMU Munich
Main research focus
Extensive expertise in areas of basic sciences (cell biology, hormone and signaling molecules) and clinical research on child health and development (children with chronic diseases, psycho-social dimensions)
5 out of 882; WOS h-index 71
Bussler S, …, Kiess W, et al. New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ‐glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage. Hepatology 2018;68:1319-30.
Poulain T, …, Kiess W, et al. The LIFE Child study: a population-based perinatal and pediatric cohort in Germany. Eur J Epidemiol 2017;32:145-58.
Garten, A, …, Kiess W. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol 2015;11:535-46. (~200 citations)
Syrbe S, …, Kiess W, et al. De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet 2015;47:393-9.
Kiess W et al. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J Biol Chem 1987;262:12745-51.
Awards: DAG-Medal (German Society for the Study of Obesity, 2018), Andrea Prader Prize for life time achievements (European Society of Pediatric Endocrinology, 2016), Robert Vines Lecture (Australian Pediatric Endocrine Group, 2016), Adalbert-Czerny-Prize (German Society of Pediatrics, 1994), Marius-Tausk-Förderpreis (German Society of Endocrinology, 1985); Societies: President of the 30th Meeting of the German Society for the Study of Obesity (2014), President 51st Meeting, European Society for Pediatric Endocrinology (2012), President 41st l Meeting of the German Diabetes Society (2006), President German Diabetes Society (2003-05), Conference President of the German Society for Pediatrics and Child Health (2002), Treasurer European-Society of Paediatric Endocrinology (1999-2009)